ArticleThe Journal of biological chemistry2018

Protein phosphatase PP5 controls bone mass and the negative effects of rosiglitazone on bone through reciprocal regulation of PPARγ (peroxisome proliferator-activated receptor γ) and RUNX2 (runt-related transcription factor 2).

Lance A Stechschulte et al.PubMed ↗Full text ↗Publisher ↗

No numbers read from the abstract.